Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus

By Menghini R.   Uccioli L.   Vainieri E.   Pecchioli C.   Casagrande V.   Stoehr R.   Cardellini M.   Porzio O.   Rizza S.   Federici M.  

Acta Diabetologica, Vol. 50, Iss. 6, 2013-12 ,pp. : 907-910

Springer Publishing Company

Access to resources Recommend Favorite

The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status

By Heraclides A.   Jensen T.   Rasmussen S.   Eugen-Olsen J.   Haugaard S.   Borch-Johnsen K.   Sandbæk A.   Lauritzen T.   Witte D.  

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1542-1546

Springer Publishing Company

Access to resources Recommend Favorite

GLP-1 receptor agonists in the treatment of Type 2 diabetes

By Ahrén Bo  

Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 401-413

Future Medicine

Access to resources Recommend Favorite

Reducing the Risk of Type 2 Diabetes - Early Identification of High-Risk Individuals and Treatment with Acarbose

By  

Current Diabetes Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite

Biological correlates of day-to-day variation in flow-mediated dilation in individuals with Type 2 diabetes: a study of test–retest reliability

By West S.   Wagner P.   Schoemer S.   Hecker K.   Hurston K.   Likos Krick A.   Boseska L.   Ulbrecht J.   Hinderliter A.  

Diabetologia, Vol. 47, Iss. 9, 2004-09 ,pp. : 1625-1631

Springer Publishing Company

Access to resources Recommend Favorite